Description: Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international. The Company's therapeutic areas of focus include cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology and travel health. The Company's product categories include prescription only medicines, over the counter medications, medical devices, cosmetics and nutritional supplements. The Company's products include SkinSafe, Lift Plus, AbsorbaGel, DeoGel, LaVera, ClearWay, Gelclair, ImmuCyst 81mg, Hydromol, MacuShield, Lypsyl, Anbesol Adult Strength Gel, MolluDab and Ashton & Parsons Infants' Powders.
Home Page: www.alliancepharmaceuticals.com
APH Technical Analysis
Avonbridge House
Chippenham,
SN15 2BB
United Kingdom
Phone:
44 12 4946 6966
Officers
| Name | Title |
|---|---|
| Mr. Andrew Timothy Franklin | Interim CEO, CFO & Exec. Director |
| Mr. Peter Jonathan Butterfield | CEO & Exec. Director (Leave of Absence) |
| Mr. Stephen Kidner | Chief Scientific Affairs & Operations Officer |
| Ms. Cora Maeve McCallum C.F.A. | Head of Investor Relations & Corp. Communications |
| Mr. Alex Duggan | Chief Commercial & Corp. Devel. Officer |
| Ms. Janice Timberlake | Chief People & Infrastructure Officer |
| Mr. Steve Lobb | Head of Hydromol |
| Mr. David Hope | Head of Secondary Care |
| Mr. Rajiv Ghidiyal | Head of APAC, EMEA & Americas |
| Mr. Karim Husny | Head of International |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| Forward PE: | 6.566 |
|---|---|
| Trailing PE: | 29.6 |
| Price-to-Book MRQ: | 0.8002 |
| Price-to-Sales TTM: | 1.6525 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 250 |